# VBI Vaccines Inc. New (VBIV)

Source: https://www.quantisnow.com/company/VBIV
Generated: 2026-11-20T06:07:53.432Z

- Ticker: VBIV
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: vbivaccines.com

## About

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. The company primarily serves physicians and pharmacists through direct sales. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition For Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.

## Latest VBIV news and filings

- 2024-08-02 20:05 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Bankruptcy or Receivership, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-bankruptcy-or-5640237)
- 2024-08-02 20:05 UTC [VBI Vaccines Provides an Update on its Restructuring Proceedings](https://www.quantisnow.com/insight/vbi-vaccines-provides-an-update-on-its-restructuring-proceedings-5640185)
- 2024-07-30 14:28 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Other Events](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-bankruptcy-or-5632714)
- 2024-07-30 13:55 UTC [Conference Announcement] [VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives](https://www.quantisnow.com/insight/vbi-vaccines-initiates-restructuring-proceedings-under-ccaa-to-implement-a-5632683)
- 2024-06-25 20:15 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-submission-of-5576508)
- 2024-06-25 20:15 UTC [VBI Vaccines Announces Results of Annual General Meeting](https://www.quantisnow.com/insight/vbi-vaccines-announces-results-of-annual-general-meeting-5576493)
- 2024-05-29 12:02 UTC [Market Chatter] [VBI Vaccines Reports New Tumor Response Data From Ongoing Randomized Controlled Phase 2b Study Of VBI-1901 For Patients With Recurrent Glioblastoma](https://www.quantisnow.com/insight/vbi-vaccines-reports-new-tumor-response-data-from-ongoing-randomized-5521943)
- 2024-05-29 12:00 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-regulation-fd-5521934)
- 2024-05-29 12:00 UTC [VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients](https://www.quantisnow.com/insight/vbi-vaccines-announces-new-tumor-response-data-from-ongoing-randomized-5521920)
- 2024-05-24 21:00 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-notice-of-5517400)
- 2024-05-22 12:04 UTC [Market Chatter] [VBI Vaccines To Present New Interim Phase 2b Data From VBI-1901 In Recurrent Glioblastoma Patients In Poster Presentation At 2024 ASCO Annual Meeting](https://www.quantisnow.com/insight/vbi-vaccines-to-present-new-interim-phase-2b-data-from-5509244)
- 2024-05-22 12:00 UTC [VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients](https://www.quantisnow.com/insight/vbi-vaccines-announces-poster-presentation-at-2024-asco-annual-meeting-5509191)
- 2024-05-15 20:16 UTC [SEC Form 424B5] [SEC Form 424B5 filed by VBI Vaccines Inc. New](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-vbi-vaccines-inc-new-5493711)
- 2024-05-15 20:18 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-entry-into-5493627)
- 2024-05-15 20:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by VBI Vaccines Inc. New](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-vbi-vaccines-inc-new-5493052)
- 2024-05-15 20:04 UTC [Market Chatter] [VBI Vaccines Q1 EPS $(0.73) Up From $(3.22) YoY, Sales $1.21M Up From $485.00K YoY](https://www.quantisnow.com/insight/vbi-vaccines-q1-eps-073-up-from-322-yoy-sales-5493047)
- 2024-05-15 20:00 UTC [Public Offering] [VBI Vaccines Reports First Quarter 2024 Financial Results](https://www.quantisnow.com/insight/vbi-vaccines-reports-first-quarter-2024-financial-results-5492952)
- 2024-05-01 20:15 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-other-events-5449776)
- 2024-04-29 20:15 UTC [SEC Form ARS filed by VBI Vaccines Inc. New](https://www.quantisnow.com/insight/sec-form-ars-filed-by-vbi-vaccines-inc-new-5441305)
- 2024-04-29 20:10 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by VBI Vaccines Inc. New](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-vbi-vaccines-inc-new-5441157)
- 2024-04-29 20:05 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by VBI Vaccines Inc. New](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-vbi-vaccines-inc-new-5440984)
- 2024-04-17 20:16 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by VBI Vaccines Inc. New (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-vbi-vaccines-inc-new-5416124)
- 2024-04-16 12:01 UTC [SEC Form 10-K] [SEC Form 10-K filed by VBI Vaccines Inc. New](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-vbi-vaccines-inc-new-5412029)
- 2024-04-16 12:00 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-results-of-5412017)
- 2024-04-16 12:00 UTC [Public Offering] [VBI Vaccines Reports Full Year 2023 Financial Results](https://www.quantisnow.com/insight/vbi-vaccines-reports-full-year-2023-financial-results-5411988)
- 2024-04-11 20:07 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-entry-into-5406075)
- 2024-04-11 20:05 UTC [Public Offering] [VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/vbi-vaccines-announces-closing-of-2-million-registered-direct-offering-5406008)
- 2024-04-11 17:33 UTC [Market Insight] [Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-fastenal-shares-are-trading-lower-by-around-7-here-5405684)
- 2024-04-11 13:06 UTC [SEC Form 424B5] [SEC Form 424B5 filed by VBI Vaccines Inc. New](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-vbi-vaccines-inc-new-5405121)
- 2024-04-09 19:55 UTC [Market Chatter] [VBI Vaccines shares are trading lower after the company announced a $2 million registered direct offering at $0.88 per share.](https://www.quantisnow.com/insight/vbi-vaccines-shares-are-trading-lower-after-the-company-announced-5400526)
- 2024-04-09 18:48 UTC [Market Chatter] [VBI Vaccines Announces $2M Registered Direct Offering At $0.88/Share](https://www.quantisnow.com/insight/vbi-vaccines-announces-2m-registered-direct-offering-at-088share-5400447)
- 2024-04-09 18:45 UTC [Public Offering] [VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/vbi-vaccines-announces-2-million-registered-direct-offering-priced-at-the-market-5400440)
- 2024-04-09 10:05 UTC [Market Insight] [Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-biophytis-shares-are-trading-higher-by-around-55-here-5398919)
- 2024-04-03 12:07 UTC [Market Chatter] [VBI Vaccines Presents Early Tumor Response Data From Randomized Controlled Phase 2b Study Of VBI-1901 In Recurrent Glioblastoma; Early Data From Patients Eligible For Evaluation At Week 12 Show Two Observations Of Stable Disease, Indicating No Tumor Progression, In VBI-1901 Treatment Arm](https://www.quantisnow.com/insight/vbi-vaccines-presents-early-tumor-response-data-from-randomized-controlled-5387279)
- 2024-04-03 12:00 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-regulation-fd-5387235)
- 2024-04-03 12:00 UTC [VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma](https://www.quantisnow.com/insight/vbi-vaccines-presents-encouraging-early-tumor-response-data-from-randomized-5387190)
- 2024-04-02 12:09 UTC [Market Chatter] [VBI Vaccines Expands Collaboration With Canadian Government; Says Under The New Agreement, The Remaining C$28M Of Funding Available Under The Previously Committed C$56M Will Be Directed Toward The Development Of VBI's MLE Platform](https://www.quantisnow.com/insight/vbi-vaccines-expands-collaboration-with-canadian-government-says-under-the-5383064)
- 2024-04-02 12:08 UTC [Market Chatter] [VBI Vaccines To Expand Strategic Partnership With Canadian Government; Partnership To Direct CAD$28M Of Funding Remaining Under Original CAD$56M Award To Continue Development Of Proprietary Tech Platforms](https://www.quantisnow.com/insight/vbi-vaccines-to-expand-strategic-partnership-with-canadian-government-partnership-5383061)
- 2024-04-02 12:00 UTC [SEC Form 8-K] [VBI Vaccines Inc. New filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vbi-vaccines-inc-new-filed-sec-form-8-k-regulation-fd-5383002)
- 2024-04-02 12:00 UTC [VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform](https://www.quantisnow.com/insight/vbi-vaccines-announces-expanded-strategic-partnership-with-canadian-government-to-5382948)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/VBIV
- Earnings history: https://www.quantisnow.com/earnings/VBIV
- Dividend history: https://www.quantisnow.com/dividends/VBIV
- Insider transactions: https://www.quantisnow.com/insiders/VBIV
- Options chain: https://www.quantisnow.com/options/VBIV
- SEC 8-K filings only: https://www.quantisnow.com/company/VBIV/8-k
- RSS and alerts for VBIV: https://www.quantisnow.com/docs/rss-feeds.md
